Ashley McEvoy, executive vice president, worldwide chair of Johnson & Johnson’s medtech business, said the company’s orthopedics sector — such as hips and trauma — is gaining market share, but spine has been losing ground.
Johnson & Johnson said it will develop a spine robot on the back of the success of its Velys system for total knee replacement, which recently surpassed 10,000 cases, according to the company.
Ms. McEvoy did not provide a timeline for the robot but said “three important innovations” are expected to reshape the company’s spine portfolio “in the next couple of years.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
